Tag Archives: Dr. Stefan Danner

EMA Draft Guidelines For Biosimilar Antibodies Released

From Dr. Stefan Danner On November 18, 2010, the European Medicines Agency (EMA) released draft versions of two guidelines relating to the regulatory approval of monoclonal antibodies: the “Guideline on biological medicinal products containing monoclonal antibodies”1 and the “Guideline on … Continue reading

Posted in Non-U.S. Practice | Tagged , , , , | Leave a comment